VTGNVistaGen Therapeutics Inc
VTGN
VistaGen Therapeutics Inc18,242
Mkt Cap
$23.3MVolume
497,523.0052W High
$5.1452W Low
$0.43PE Ratio
-0.37VTGN Fundamentals
Price
$0.5963Prev Close
$0.586Open
$0.5650D MA
$0.7071Beta
1.84Avg. Volume
1.32MEPS (Annual)
-$1.67P/B
0.46Rev/Employee
$8,526.32$1.78
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities...
PR Newswire·15h ago
Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN
Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the...
PR Newswire·15h ago
VTGN DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Vistagen (VTGN) Investors of Securities Class Action Deadline on March 16, 2026
VTGN DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Vistagen (VTGN) Investors of Securities Class Action Deadline on March 16, 2026 VTGN DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Vistagen (VTGN...
PR Newswire·2d ago
VTGN Deadline: VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit
VTGN Deadline: VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit VTGN Deadline: VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc...
PR Newswire·3d ago
LEVI & KORSINSKY, LLP INVESTIGATING ALLEGED CLINICAL TRIAL DESIGN DEFICIENCIES AT VISTAGEN THERAPEUTICS -- CLASS ACTION FILED
LEVI & KORSINSKY, LLP INVESTIGATING ALLEGED CLINICAL TRIAL DESIGN DEFICIENCIES AT VISTAGEN THERAPEUTICS -- CLASS ACTION FILED LEVI & KORSINSKY, LLP INVESTIGATING ALLEGED CLINICAL TRIAL DESIGN...
PR Newswire·5d ago
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 16, 2026 in Vistagen Lawsuit - VTGN
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 16, 2026 in Vistagen Lawsuit - VTGN Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 16, 2026 in...
PR Newswire·5d ago
Vistagen to Participate in the 46th Annual TD Cowen Healthcare Conference
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product...
Business Wire·5d ago
Class Action Filed Against Vistagen Therapeutics, Inc. (VTGN) - March 16, 2026 Deadline to Join - Contact The Gross Law Firm
Class Action Filed Against Vistagen Therapeutics, Inc. (VTGN) - March 16, 2026 Deadline to Join - Contact The Gross Law Firm Class Action Filed Against Vistagen Therapeutics, Inc. (VTGN) - March 16...
PR Newswire·6d ago
VTGN DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics (VTGN) Investors of Securities Class Action Deadline on March 16, 2026
VTGN DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics (VTGN) Investors of Securities Class Action Deadline on March 16, 2026 VTGN DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds...
PR Newswire·9d ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vistagen Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - VTGN
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vistagen Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - VTGN INVESTOR ALERT: Pomerantz Law...
PR Newswire·11d ago
<
1
2
...
>